LBRX
LB Pharmaceuticals Inc Common StockstockNASDAQ
At CloseOct 2, 2026 3:59:59 PM EDT
37.01USD-0.804%(-0.30)388,884
Pre-marketOct 5, 2026 8:54:30 AM EDT
36.36USD-1.756%(-0.65)
Loading…
Loading…
1.20B
Previous Close
$37.28
Beta
0.53
52-Week High
$50.16 2026-08-25
52-Week Low
$14.32 2025-11-11
SMA 50
$43.87
SMA 200
$30.90
Avg. Vol 10D
420,164
Avg. Vol 30D
324,673
Avg. Vol 90D
327,714
Relative Vol
1.20
32.26M
20.76M
64.37%
5,617,182
27.05%
21.45
59%/41%
74.45%
63.18%
0.4200%
100,000
27,819
14,530
40,000
Nov 5, 2026 (31d)
Oct 2, 2026
Needham initiates LB Pharmaceuticals stock with buy rating ·
Investing.com
Sep 23, 2026
Sep 15, 2026
LB Pharmaceuticals names Susan Kozauer as chief medical officer ·
Investing.com
LBRX Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 37.89 | 2026-09-28 | -2.14% | -1.866 |
| 1M | 49.34 | 2026-09-04 | -24.85% | 0.769 |
| 3M | 33.41 | 2026-07-06 | +10.98% | 0.426 |
| 6M | 26.94 | 2026-04-06 | +37.64% | 0.717 |
| 1Y | 15.14 | 2025-10-06 | +144.91% | 0.530 |
| 2Y | 17.30 | 2025-09-11 | +114.33% | — |
LBRX Stock Summary
LB Pharmaceuticals Inc Common Stock (NASDAQ:LBRX) stock price today is $37.08, and today's volume is 388,886. LBRX is down 0.536% today. The 30 day average volume is 324,673. LBRX market cap is $1.20B with 32.26M shares outstanding.